An Open-Label, Long-Term Extension Study to Evaluate the Safety and Tolerability Deflazacort

Summary

This is an open label, long-term extension study in approximately 24 male DMD subjects consisting of children (ages 4-12, inclusive) and adolescents (ages 13-16, inclusive) who participated in the MP-104-CL-005 PK study.

Timeline

Start

2014-12

Primary completion

2017-08-24

Completion

2017-08-24

Drugs

Indications